JALKANEN SIRPA has a total of 19 patent applications. Its first patent ever was published in 1993. It filed its patents most often in United States, Canada and Finland. Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are TOLERA THERAPEUTICS INC, ALLERGENE LTD and XENOME LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Canada | 3 | |
#3 | Finland | 3 | |
#4 | Australia | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Israel | 1 | |
#7 | Norway | 1 | |
#8 | New Zealand | 1 | |
#9 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Machines | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Unspecified technologies | |
#5 | Special foods | |
#6 | Foods | |
#7 | Microorganisms | |
#8 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Jalkanen Sirpa | 18 |
#2 | Salmi Marko | 16 |
#3 | Jalkanen Markku | 4 |
#4 | Irjala Heikki | 1 |
Publication | Filing date | Title |
---|---|---|
US2008206313A1 | Compositions useful especially for treatment or prevention of metabolic syndrome | |
US2008213176A1 | Compositions for Targeting Amine Oxidases in Vivo | |
FI20030480A0 | A method of treating inflammatory conditions | |
FI20030467A0 | Procedure for treating inflammatory conditions | |
FI956041A0 | Compositions and diagnostic methods using monoclonal antibodies against CD44V6 | |
AU6972694A | Compositions and diagnostic methods using monoclonal antibodies against CD44v6 |